WHWK aadibio.com Final Profit

Corporate emblem and logo of aadibio.com (WHWK)

Optimized biomaterial supply chains ensure the stability of Aadi Bioscience Inc (WHWK) processes. The company's current net result demonstrates the impact of this foundation, where the value -0.08 shows the current profit magnitude. This trend relies on the unique Nab-platform for rare tumor therapy; however, a high dependence on the success of single drugs creates serious financial risks in the event of failed tests.

WHWK (Aadi Bio) Net Profit history from 03/20/2025 to 10/29/2026

Analytical breakdowns and data insights for company aadibio.com (WHWK)

- stock value and consensus price forecast:
Market Price Aadi Bioscience|WHWK - Price Target Chart
- market capitalization data:
Market Value WHWK|WHWK - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value of a Share Aadi Bioscience|WHWK - Book Capitalization|Market Cap to Net Assets Ratio aadibio.com|WHWK - Cumulative Company Assets
- debt and solvency information:
Total Debt to Capital Aadi Bioscience Inc|WHWK - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Aadi Bioscience|WHWK - Company Aggregate Debts|Debts to Book Value WHWK|WHWK - Company Long-Term Debts|Company Short-Term Debts Aadi Bioscience|Quick Ratio aadibio.com
- net income and valuation multiples indicators:
WHWK - Net Profit
Fundamental valuation:WHWK Aadi Bio
Manufactured product of Aadi Bioscience, Inc.

Aadi Bioscience Inc. profit represents the final financial result net of all operating and tax expenses, reflecting the actual efficiency of cash flow generation. By analyzing the company's operating result, an investor can see the burn rate of Aadi Bioscience Inc., which is critical during the current restructuring and the reduction of research programs to preserve the liquidity of the key commercial project.

Direct competitors

Company Net Income BeiGene Oncology (ONC)|Company Net Income Halozyme Therapeutics|RVMD: Final Profit|Net Income AAPG (Ascentage Pharma)|CGON (CG Oncology Inc) - Final Profit|Net Profit URGN (UroGen)|BCAX - Net Income|PSNL: Net Income|ERAS - Net Profit|Delcath Systems (DCTH) - Company Net Income|Y-mAbs Therapeutics Inc - Final Profit|AURA (Aura Bio) - Net Profit|Company Net Income Candel CADL|Net Profit ARAY|Net Profit sellaslifesciences.com (SLS)|Net Profit ACTU (Actuate Therapeutics)|Net Profit Citius Oncology Inc. CTOR|TuHURA - Net Profit|TARA (Protara Tx) - Company Profit|FATE: Net Profit|TCRX - Net Financial Result|Net Income CSBR|XBIT: Final Profit|Net Profit CVM|Company Net Income OSTX (OS Therapies, Inc.)|Net Profit RADX (Radiopharm Theranostics Limited)|Net Financial Result Artiva Biotherapeutics Inc. (ARTV)|ANL - Company Net Income|Company Net Income Veru Inc|Tempest Tx (TPST) - Company Net Income|XLO - Net Financial Result|RENB (Renovaro Biosciences) - Net Profit|Net Income Mural Bio (MURA)|Net Profit KAPA|Net Financial Result onkuretherapeutics.com|Net Profit GDTC (CytoMed Therapeutics Limited)|Curis Inc. (CRIS) - Company Net Income|APLM - Company Net Income|THAR (tharimmune.com) - Company Profit|ADVB: Net Profit|Net Income Genprex Inc.|CLDI (Calidi Biotherapeutics Inc.) - Net Profit|Company Net Income Sunshine Biopharma Inc. SBFM|Net Income XBIO (Xenetic Biosciences)|SLRX (salariuspharma.com) - Final Profit|Net Profit PPBT (Purple Biotech Ltd.)|Net Financial Result American Oncology Network Inc (AONC)|BGNE - Company Net Income|CKPT (Checkpoint Therapeutics Inc) - Company Profit|ELEV: Net Profit|Net Income iCAD|Net Income IKNA|Net Income Notable Labs Ltd (NTBL)|Net Profit VIRX|MOR (MorphoSys Corporation) - Final Profit|NAYA Biosciences - Net Income|AAPGV - Net Income